Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The… Read More
Seattle startup raises $2M to expand technologies for immunotherapy Take a quick browse through Seattle’s biotech scene, and you’ll notice a pattern. Immunotherapy — using the body’s immune system to fight… Read More
